A detailed history of Diamond Hill Capital Management Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Diamond Hill Capital Management Inc holds 70,099 shares of AUPH stock, worth $629,489. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,099
Previous 70,099 -0.0%
Holding current value
$629,489
Previous $400,000 28.25%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$4.93 - $9.31 $74,048 - $139,836
15,020 Added 27.27%
70,099 $351,000
Q4 2023

Feb 05, 2024

BUY
$7.13 - $9.49 $188,980 - $251,532
26,505 Added 92.76%
55,079 $495,000
Q1 2022

May 11, 2022

BUY
$10.05 - $22.48 $94,369 - $211,087
9,390 Added 48.95%
28,574 $354,000
Q4 2021

Feb 08, 2022

BUY
$17.78 - $33.08 $12,712 - $23,652
715 Added 3.87%
19,184 $439,000
Q2 2021

Aug 03, 2021

BUY
$10.0 - $14.52 $184,690 - $268,169
18,469 New
18,469 $239,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.27B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Diamond Hill Capital Management Inc Portfolio

Follow Diamond Hill Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diamond Hill Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Diamond Hill Capital Management Inc with notifications on news.